Molecular Assemblies, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Molecular Assemblies, Inc.
Finance Watch: Arbor, Acrivon, Bit.Bio Close VC Mega-Rounds
Private Company Edition: Arbor is developing drugs based on proprietary gene editors, Acrivon is applying proteomics to precision cancer therapies, and bit.bio is producing differentiated cell products. Also, Marengo launches with $80m, Sanofi invests up to $60m in Gyroscope and Shasqi raises $50m.
Start-Up Previews, July 2015
This month's profiles: InPress Technologies, MaRVis Medical, Medherant, Molecular Assemblies, MyoPowers, Potrero Medical, Revolution Medicines, and Rivanna Medical
Molecular Assemblies Inc.
Molecular Assemblies Inc. aims to commercialize a “green” approach to DNA synthesis called EcoDNA. The start-up expects the biologically and enzymatically based technology to produce DNA strands up to 30 times longer than those made with the classical chemical methods.
- Research, Analytical Equipment & Supplies
- Large Molecule
- Nanotechnology, Chips, etc.
- Synthesis Technologies, Production Processes
Drug Discovery Tools
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.